These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 38672781)
1. Approaches to Characterize and Quantify Extracellular Vesicle Surface Conjugation Efficiency. Goldbloom-Helzner L; Bains H; Wang A Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672781 [TBL] [Abstract][Full Text] [Related]
2. Assessing the conjugation efficiency of surface-modified extracellular vesicles using single nanovesicle analysis technologies. Goldbloom-Helzner L; Bains H; Loll EG; Henson T; Mizenko RR; Kumar P; Tan C; Farmer DL; Carney RP; Wang A Nanoscale; 2024 Nov; 16(45):20903-20916. PubMed ID: 39310954 [TBL] [Abstract][Full Text] [Related]
3. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy. Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755 [TBL] [Abstract][Full Text] [Related]
4. A Dual-Reporter Platform for Screening Tumor-Targeted Extracellular Vesicles. Kanada M; Linenfelser L; Cox E; Gilad AA Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335849 [TBL] [Abstract][Full Text] [Related]
5. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. Nasiri Kenari A; Cheng L; Hill AF Methods; 2020 May; 177():103-113. PubMed ID: 31917274 [TBL] [Abstract][Full Text] [Related]
6. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Claridge B; Lozano J; Poh QH; Greening DW Front Cell Dev Biol; 2021; 9():734720. PubMed ID: 34616741 [TBL] [Abstract][Full Text] [Related]
8. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery. Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546 [TBL] [Abstract][Full Text] [Related]
9. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles. Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151 [TBL] [Abstract][Full Text] [Related]
10. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives. Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599 [TBL] [Abstract][Full Text] [Related]
11. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. Liu Q; Li D; Pan X; Liang Y J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008 [TBL] [Abstract][Full Text] [Related]
12. Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake. Zhang J; Brown A; Johnson B; Diebold D; Asano K; Marriott G; Lu B Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559058 [TBL] [Abstract][Full Text] [Related]
13. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity. Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896 [TBL] [Abstract][Full Text] [Related]
14. M1 Macrophage-Derived Exosome-Mimetic Nanovesicles with an Enhanced Cancer Targeting Ability. Baek S; Jeon M; Jung HN; Lee W; Hwang JE; Lee JS; Choi Y; Im HJ ACS Appl Bio Mater; 2022 Jun; 5(6):2862-2869. PubMed ID: 35561258 [TBL] [Abstract][Full Text] [Related]
15. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Bhatta R; Han J; Liu Y; Bo Y; Lee D; Zhou J; Wang Y; Nelson ER; Chen Q; Zhang XS; Hassaneen W; Wang H Nat Commun; 2023 Dec; 14(1):8047. PubMed ID: 38052869 [TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer. Zhao Q; Hai B; Kelly J; Wu S; Liu F Stem Cell Res Ther; 2021 Jan; 12(1):29. PubMed ID: 33413659 [TBL] [Abstract][Full Text] [Related]
18. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521 [TBL] [Abstract][Full Text] [Related]
19. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851 [TBL] [Abstract][Full Text] [Related]
20. Application of engineered extracellular vesicles for targeted tumor therapy. Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]